Thomas Powles MBBS, MRCP, MD

Thomas Powles, MBBS, MRCP, MD, is a professor of genitourinary oncology and the director of the Barts Cancer Centre at St. Bartholomew’s Hospital in London, England.

Articles by Thomas Powles MBBS, MRCP, MD

Dr. Powles on Biomarkers for Immunotherapy in Bladder Cancer

ByThomas Powles MBBS, MRCP, MD

November 13th 2018

Thomas Powles MBBS, MRCP, MD, professor of Genitourinary Oncology, lead, Solid Tumour Research, Barts Cancer Institute, director, Barts Cancer Centre, discusses biomarkers for immunotherapy in bladder cancer.

Thomas Powles MBBS, MRCP, MD

Articles by Thomas Powles MBBS, MRCP, MD

Dr. Powles on Biomarkers for Immunotherapy in Bladder Cancer

Trending on OncLive

Divesiran Reduces Phlebotomy Burden and Improves Iron Stores in Polycythemia Vera

Luspatercept Sustains Long-Term Transfusion Independence, Favorable OS Trend in ESA-Naive Lower-Risk MDS

Study Identifies RNA Surveillance Defect That Fuels Melanoma Through Endogenous Retroviral RNA

FDA Grants Breakthrough Device Designation to Merlin CP-GEP for Early-Stage Melanoma Risk Stratification

Belantamab Mafodotin Yields Sustained MRD Negativity in R/R Myeloma